KEI Research Note 2014:3 (draft 2) Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results Elizabeth Rajasingh November 27, 2014

First Page		Document Content
Date: 2014-11-17 12:49:45 Health Drug discovery Pharmaceutical industry Food and Drug Administration Pharmaceuticals policy Clinical trial Drug development Orphan drug Prescription Drug User Fee Act Pharmaceutical sciences Pharmacology Clinical research		KEI Research Note 2014:3 (draft 2) Size of Clinical Trials, data from the FDA 2010 NME and BLA approvals, preliminary results Elizabeth Rajasingh November 27, 2014 Add to Reading List Source URL: keionline.org Download Document from Source Website File Size: 119,24 KB Share Document on Facebook

	PDF Document DocID: 1xvUb - View Document
	PDF Document DocID: 1xc8R - View Document
	Institute of Pharmacology www.pki.unibe.ch Introduction Prof. Dr. Dr. Stephan von Gunten MD PhD MME DocID: 1vqsj - View Document
	Jansone et al.: Intrinsic Activity, 2017; 5 (Suppl.2):A1.6 doi:IA.5.S2-A1.6 published online: 16 October 2017 2nd International Conference in Pharmacology: From Cellular Processes to Drug Targets Rīga, Latvia DocID: 1vlJU - View Document
	Human cells Notable for research in: -Medecine: Diseases and cancers -Cell Biology -Pharmacology DocID: 1vk1K - View Document